5α-reductase type 3 enzyme in benign and malignant prostate. - Wikidata - wikimedia - TriplyDB

5α-reductase type 3 enzyme in benign and malignant prostate.

5α-reductase type 3 enzyme in benign and malignant prostate.

http://www.wikidata.org/entity/Q37712234

about

Androgen biosynthesis in castration-resistant prostate cancer Intratumoral steroidogenesis in castration-resistant prostate cancer: a target for therapy.Influence of Panax ginseng on Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia.Genetic defects in dolichol metabolism.Experimental and early investigational drugs for androgenetic alopecia.Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization.UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression.Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.A carbon 21 steroidal metabolite from progestin, 20β-hydroxy-5α-dihydroprogesterone, stimulates the androgen receptor in prostate cancer cells.Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade.Identification of 5α-reductase isoenzymes in canine skin.Characterization of Precursor-Dependent Steroidogenesis in Human Prostate Cancer Models

P2860

Q27026044-CA325567-FEAD-4612-8B13-55559DFAF2BB Q34294888-DFEFA179-D666-4E86-B8A1-2B807CA8CB91 Q34791930-E04AD309-6CC0-4BEC-9C8B-6E986825F816 Q34798492-9485A380-0C40-43F8-B44E-92AD5E10257D Q38660822-FA3E9A1A-4798-4C27-BA2E-E2936B1DD234 Q38661520-4717FDE9-CBFC-4A45-9211-B7493703D5FA Q38862028-9E2901EB-E1A3-4D65-ABE5-E1A3FA420873 Q40969104-8C347CD3-26B7-4BC6-A7D5-355629425015 Q44768432-F15AFCB5-7EB5-4359-8422-048E7C9EEB02 Q48197264-32B470A5-FE64-4F1F-B47F-96C9E2F5C519 Q52655045-8B602731-8D85-4A4A-91F7-E758C4819825 Q53426248-454064EB-5DF7-487D-8AC8-EE728F67ACAE Q58708797-F6A6F367-B8CB-44CD-8A39-CBF439B24F74

P2860

5α-reductase type 3 enzyme in benign and malignant prostate.

http://www.wikidata.org/entity/Q37712234

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

5α-reductase type 3 enzyme in benign and malignant prostate.

@en

5α-reductase type 3 enzyme in benign and malignant prostate.

@nl

type

label

5α-reductase type 3 enzyme in benign and malignant prostate.

@en

5α-reductase type 3 enzyme in benign and malignant prostate.

@nl

prefLabel

5α-reductase type 3 enzyme in benign and malignant prostate.

@en

5α-reductase type 3 enzyme in benign and malignant prostate.

@nl

P1433

Q37712234-26ADCA2B-70A6-4B18-965A-6E0098D2B0C0

P1476

Q37712234-5B03EDC1-86D6-49C0-9202-9847259C9AB7

P2093

Q37712234-113E0495-4CF9-4868-B876-D98ACED442CF

Q37712234-17DC36DC-883F-4816-9EBF-D8B23FDC7E73

Q37712234-695D5EF5-CD69-462C-A04C-5F71CFAA1642

Q37712234-B987A37C-6A78-4C46-861D-0D2485B5432E

Q37712234-BC3AA049-4EC4-420B-975A-B625A18A2EF8

Q37712234-E61648E6-19D5-446D-B297-7C2D0A76445A

Q37712234-F5E851A4-EA5A-4187-8A7F-499F0FDCEA64

P2860

Q37712234-06E3CBCE-BE26-4C70-B3A1-6B7C37042B5B

Q37712234-0B99C739-ED61-4399-8751-D8EBFE443B25

Q37712234-0BEBD158-716B-4FFB-A6A0-91AB29485A01

Q37712234-1128920B-C4B2-4E5F-88BF-69F45514DA72

Q37712234-13C170E4-B55A-44C0-AA90-E273385E0643

Q37712234-1442B3EE-FA3E-4749-9461-65AFF5E78940

Q37712234-1B57C083-FD85-4683-B41A-F3D598E353C1

Q37712234-1DFC2A8A-D697-4D98-921B-B69178EE661D

Q37712234-221F4C57-FD17-411D-B62E-CE603CD2E3ED

Q37712234-268703E6-B265-4785-9A04-8F3D461B7494

P304

Q37712234-10B9BAD2-78A8-47BB-8C83-3F3E7D7262C4

P31

Q37712234-5648A3A1-AFFE-40B0-83FF-351343E9444E

P356

Q37712234-55F3AB43-0FBA-4449-BFC4-BD2D9071A16F

P433

Q37712234-EDB8E2F4-1342-470F-B2EF-15E130D6F8EB

P478

Q37712234-1F5AD143-63C4-4807-AF1B-D6C9A52B6777

P577

Q37712234-1C902B23-1A8F-4342-ACB0-4775FF28CB95

P5875

Q37712234-C97D4EB1-BFD2-491E-BFC8-C4D31802658C

P698

Q37712234-4D076643-34BB-4C3B-A97F-0E93673490AB

P932

Q37712234-2C8E2BFC-DB78-4514-9714-553E7E1B31C5

P356

P1433

P1476

5α-reductase type 3 enzyme in benign and malignant prostate.

@en

P2093

Alejandro Godoy

http://www.w3.org/2001/XMLSchema#string

Gary J Smith

http://www.w3.org/2001/XMLSchema#string

James L Mohler

http://www.w3.org/2001/XMLSchema#string

Mark A Titus

http://www.w3.org/2001/XMLSchema#string

Olga G Kozyreva

http://www.w3.org/2001/XMLSchema#string

Varun Maher

http://www.w3.org/2001/XMLSchema#string

Yun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer

SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder

Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones

Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes

Effect of dutasteride on the risk of prostate cancer.

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.

Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer.

Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy

Enzyme promiscuity: a mechanistic and evolutionary perspective.

5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.

P304

235-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.22745

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258036822

http://www.w3.org/2001/XMLSchema#string

P698

24150795

http://www.w3.org/2001/XMLSchema#string

P932

3992828

http://www.w3.org/2001/XMLSchema#string